Scott E. McNeil
Scott E. McNeil
Nanotechnology Characterization Laboratory, Advanced Technology Program, USA
Biography
Dr. McNeil serves as the Director of the Nanotechnology Characterization Laboratory (NCL) for Leidos Biomedical Research and Frederick National Laboratory for Cancer Research, where he coordinates preclinical characterization of nanotech cancer therapeutics and diagnostics. At the NCL, Dr. McNeil leads a team of scientists responsible for testing candidate nanotech drugs and diagnostics, evaluating safety and efficacy, and assisting with product development -- from discovery-level, through scale-up and into clinical trials.
Research Interest
Nanotechnology, Nanobiotechnology, Nanocomposites, Nanobiopharmaceutics, Nanoelectronics, Nanomedicine, Nanotoxicology, Nanoengineering, Nanofabrications, Nanofluidics, Nanohedron, Nanocars, Nanothermite, Nanotubes, Supramolecule, Nanoionics, Nanolithography, Nanoparticles, Bionanoscience